文献速递前列腺癌

机器人对比开放根治性前列腺切除术:LAPPRO试验12年随访的前列腺癌特异性生存差异

Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial.
PubMed 文献 · Eur Urol Oncol · 2025-05-23

基于非随机多中心LAPPRO试验,2008至2011年纳入4003例,3583例可分析,其中2698例(75%)行机器人辅助腹腔镜前列腺切除术(RALP),885例(25%)行开放耻骨后根治性前列腺切除术(RRP)。术后12年,RALP组前列腺癌特异性死亡率显著低于RRP组(2.0% vs 4.5%;调整HR 0.36,95%CI 0.23-0.55),全因死亡调整HR 0.81(95%CI 0.66-0.99)。研究为非随机设计,因果推断需谨慎。

要点

  • 术后12年RALP组前列腺癌特异性死亡率2.0%,显著低于RRP组的4.5%(调整HR 0.36)。
  • 全因死亡RALP组14% vs RRP组16%,调整HR 0.81(95%CI 0.66-0.99)。
  • 非随机设计限制因果推断,但结果提示机器人技术可能与更好肿瘤学结局相关。

核心结论

  • 术后12年,机器人前列腺切除术患者的前列腺癌特异性死亡率显著低于开放手术患者。
  • 结果提示机器人技术可能与更好的肿瘤学结局相关,但因果效应需谨慎解读。

研究设计与样本

  • 非随机多中心LAPPRO试验,2008至2011年入组,纳入年龄<75岁、PSA<20 ng/ml、临床分期<T4、非转移性且知情同意的患者。
  • 共4003例入组,3583例纳入当前分析,其中2698例(75%)行RALP,885例(25%)行RRP。
  • 通过基线及术后至12年的 validated 问卷和临床记录表收集数据,死亡信息取自瑞典国家死因登记册。

主要发现

  • 术后12年前列腺癌特异性死亡:RALP组55/2698(2.0%),RRP组40/885(4.5%),调整HR 0.36(95%CI 0.23-0.55)。
  • 全因死亡:RALP组371/2698(14%),RRP组145/885(16%),调整HR 0.81(95%CI 0.66-0.99)。

临床怎么用

  • 在向局限期前列腺癌患者咨询手术方式时,可参考12年随访数据:RALP与更低的 prostate cancer-specific 死亡风险相关。
  • 因非随机设计,应告知患者观察性证据的局限性,避免将关联直接解释为因果获益。

局限性

  • 研究为非随机设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Localized prostate cancer can be treated with either robot-assisted laparoscopic prostatectomy (RALP) or open retropubic radical prostatectomy (RRP). This study aimed to analyze all-cause and prostate cancer-specific mortality 12 yr after surgery. METHODS: The nonrandomized multicenter LAParoscopic Prostatectomy Robot Open (LAPPRO) trial enrolled patients from 2008 to 2011. The eligibility criteria included age <75 yr, prostate-specific antigen <20 ng/ml, clinical stage <T4, nonmetastatic disease, and informed consent. Data were collected through validated questionnaires at baseline and clinical record forms repeatedly up to 12 yr after surgery, with mortality information retrieved from Sweden's National Cause of Death Register. The main outcomes were all-cause and prostate cancer-specific mortality. KEY FINDINGS AND LIMITATIONS: Of the 4003 patients enrolled in LAPPRO, 3583 were eligible for the current analysis, of whom 2698 (75%) underwent RALP and 885 (25%) RRP. At 12 yr after surgery, prostate cancer-specific mortality was significantly lower after RALP than after RRP (55/2698 [2.0%] vs 40/885 [4.5%]; adjusted hazard ratio [HR] 0.36, 95% confidence interval [CI] 0.23-0.55). The numbers of all-cause deaths were 371/2698 (14%) in the RALP group and 145/885 (16%) in the RRP group (adjusted HR 0.81, 95% CI 0.66-0.99). The study is limited by its nonrandomized design. CONCLUSIONS AND CLINICAL IMPLICATIONS: At 12 yr after surgery, prostate cancer-specific mortality was significantly lower in patients undergoing robotic prostatectomy than in those undergoing open prostatectomy. Cautious interpretation is suggested for the possible causal effect, but the results suggest that the robotic technique is associated with a better oncological outcome.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Lantz A, Li Y, Carlsson S, et al. Robotic Versus Open Radical Prostatectomy, Differences in Prostate Cancer-specific Survival-12 Years of Follow-up in the LAParoscopic Prostatectomy Robot Open Trial. Eur Urol Oncol. 2025. PMID: 40413128. doi:10.1016/j.euo.2025.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。